Name: Molecular Genetics of Endometrial Carcinoma (en Inglés)
SKU: 58530918
Price: 2766.94 MXN
Availability: InStock
Author: Hedrick Ellenson, Lora
ISBN: 9783319827476

portada Molecular Genetics of Endometrial Carcinoma (en Inglés)

Molecular Genetics of Endometrial Carcinoma (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Hedrick Ellenson, Lora

Idioma

Inglés

N° páginas

281

Encuadernación

Tapa Blanda

Dimensiones

23.4x15.6x1.6 cm

Peso

0.42 kg.

ISBN13

9783319827476

Categorías

Genética médica
Oncología
Patología

Molecular Genetics of Endometrial Carcinoma (en Inglés)

Hedrick Ellenson, Lora (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 13 a 18 días háb.

$ 5,030.79$ 2,766.94

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 2,766.94

¡Envío Gratis! Llega entre el 28 Sep y el 06 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Molecular Genetics of Endometrial Carcinoma (en Inglés)"

This comprehensive text provides a much-needed review of a disease that is currently garnering the interest of molecular biologists, translational scientists, and clinicians. The volume includes emerging developments in the molecular genetics of endometrial carcinoma. In addition to covering the basic genetics of endometrial carcinoma, chapters also cover a wide range of signaling pathways implicated in endometrial carcinoma. A section of the book includes a number of genetically engineered mouse models, which contribute to understanding the role of various genetic alterations in the development and progression of endometrial carcinoma. These models also provide preclinical models for developing effective targeted therapeutic approaches. Endometrial carcinoma is the most common malignancy of the female genital tract in the United States and the number of cases continues to increase around the world. This book is a meant to serve as a resource for a wide range of scientists, from molecular geneticists to signal transduction biologists, as well as to both clinicians and scientists interested in developing targeted therapeutic approaches for women with endometrial carcinoma.